Back to 
ROYAL BANK OF CANADA
ROYAL BANK OF CANADA
NGEN2 quarters
Position history for ROYAL BANK OF CANADA's holdings in NERVGEN PHARMA CORP
ROYAL BANK OF CANADA holds 176,075 shares of NGEN (NERVGEN PHARMA CORP), worth $363,000 as of 2026-Q2. The position was increased (+2.4% shares). NGEN represents 0.0% of ROYAL BANK OF CANADA's portfolio.
Current Value
$363,000
Current Shares
176,075
Total Value Change
-$285,000
Total Shares Change
+4,114
Quarter-by-Quarter History
Other major holders of NGEN: LMR Partners LLP, MARSHALL WACE, LLP, UBS Group AG, BANK OF AMERICA CORP /DE/